- Home
- MNDO vs BRNS Comparison
MNDO vs BRNS Comparison
Compare MNDO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- BRNS
- Stock Information
- Founded
- MNDO 1995
- BRNS 2016
- Country
- MNDO Israel
- BRNS United Kingdom
- Employees
- MNDO N/A
- BRNS N/A
- Industry
- MNDO EDP Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- BRNS Health Care
- Exchange
- MNDO Nasdaq
- BRNS Nasdaq
- Market Cap
- MNDO 39.9M
- BRNS 41.0M
- IPO Year
- MNDO 2000
- BRNS 2021
- Fundamental
- Price
- MNDO $2.09
- BRNS $1.04
- Analyst Decision
- MNDO
- BRNS Strong Buy
- Analyst Count
- MNDO 0
- BRNS 2
- Target Price
- MNDO N/A
- BRNS $3.00
- AVG Volume (30 Days)
- MNDO 28.5K
- BRNS 46.0K
- Earning Date
- MNDO 03-05-2025
- BRNS 11-06-2024
- Dividend Yield
- MNDO 11.48%
- BRNS N/A
- EPS Growth
- MNDO N/A
- BRNS N/A
- EPS
- MNDO 0.23
- BRNS N/A
- Revenue
- MNDO $21,856,000.00
- BRNS $14,969,000.00
- Revenue This Year
- MNDO N/A
- BRNS $1,805.74
- Revenue Next Year
- MNDO N/A
- BRNS N/A
- P/E Ratio
- MNDO $9.09
- BRNS N/A
- Revenue Growth
- MNDO 2.27
- BRNS 106.21
- 52 Week Low
- MNDO $1.70
- BRNS $0.80
- 52 Week High
- MNDO $2.28
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- MNDO 69.70
- BRNS 48.42
- Support Level
- MNDO $2.02
- BRNS $0.91
- Resistance Level
- MNDO $2.04
- BRNS $1.15
- Average True Range (ATR)
- MNDO 0.03
- BRNS 0.15
- MACD
- MNDO 0.01
- BRNS -0.01
- Stochastic Oscillator
- MNDO 93.19
- BRNS 34.96
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.